Evidence map›Paper›PMID 36595152›Full record

ArticleDrug delivery and translational research2023

Studies on spray dried topical ophthalmic emulsions containing cyclosporin A (0.05% w/w): systematic optimization, in vitro preclinical toxicity and in vivo assessments.

Syed Nazrin Ruhina Rahman, Neha Agarwal, Abhinab Goswami, Amoolya Sree, Aishwarya Jala, Animith Venuganti, Apurba Deka, Roshan M Borkar, Vivek Singh, Dipankar Das and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Drug delivery and translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Sacha Inchi (Molecules (Basel, Switzerland) · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Syed Nazrin Ruhina RahmanDepartments of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Sila Katamur, Changsari, Kamrup, Assam- 781101, India.
Neha AgarwalDepartments of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Sila Katamur, Changsari, Kamrup, Assam- 781101, India.
Abhinab GoswamiDepartments of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Sila Katamur, Changsari, Kamrup, Assam- 781101, India.
Amoolya SreeDepartments of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Sila Katamur, Changsari, Kamrup, Assam- 781101, India.
Aishwarya JalaDepartments of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Sila Katamur, Changsari, Kamrup, Assam- 781101, India.
Animith VenugantiCenter for Ocular Regeneration, LV Prasad Eye Institute, Hyderabad - 500034, India.
Apurba DekaDepartment of Ocular Pathology, Sri Sankaradeva Nethralaya, Guwahati, Assam - 781028, India.
Roshan M BorkarDepartments of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Sila Katamur, Changsari, Kamrup, Assam- 781101, India.
Vivek SinghCenter for Ocular Regeneration, LV Prasad Eye Institute, Hyderabad - 500034, India.
Dipankar DasDepartment of Ocular Pathology, Sri Sankaradeva Nethralaya, Guwahati, Assam - 781028, India.
Tamilvanan ShunmugaperumalDepartments of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Sila Katamur, Changsari, Kamrup, Assam- 781101, India. tamilvanan1@yahoo.co.in.ORCID http://orcid.org/0000-0001-7338-3207
National Institute of Pharmaceutical Education and Research · INL V Prasad Eye Institute · INSankara Nethralaya · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclosporin A (CsA, 0.05% w/w)-loaded positively charged emulsions were prepared based on castor oil, chitosan, poloxamer 188, glycerin and double-distilled water. To augment the shelf/storage-stability of original emulsions, the solid-dry powder for reconstitution was made by spray drying technique. The screening (Taguchi OA) and optimization (face-centered central composite) designs produced the optimized conditions for spray drying: 40 Nm

Indexed as

CyclosporineTandem Mass SpectrometryAnimalsChromatography, LiquidEmulsionsEyeRabbitsCyclosporineEmulsionsCyclosporin AHuman corneal epithelial-2 cellsLiquid-retentiveOcular tissuesSolid-dry powder

Identifiers

PMID36595152
OpenAlexW4313455048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.